Summary
Rocket Lab Corporation (RKLB) announced on April 14, 2026, the successful closing of its acquisition of Mynaric AG, a German-based company. This strategic move was executed through a Stock Purchase Agreement, with the transaction valued at an aggregate of $155.3 million at closing. The consideration comprised a nominal cash payment and the issuance of 2,277,002 shares of Rocket Lab's Common Stock, with a portion placed in an indemnity escrow. The acquisition's financial structure was influenced by pre-closing investments made by Mynaric's sellers, which adjusted the purchase price and significantly reduced the potential for future earnout payments. This development signals a potentially completed transaction from a financial perspective regarding earnouts, subject to standard post-closing adjustments. The shares issued in connection with this acquisition were done so under a private placement exemption, not requiring SEC registration.
Key Highlights
- 1Rocket Lab Corp. has officially closed its acquisition of Mynaric AG.
- 2The total transaction value at closing was $155.3 million.
- 3Consideration included a nominal cash payment and 2,277,002 shares of RKLB Common Stock.
- 4A portion of the issued shares (109,943) has been placed in an indemnity escrow.
- 5Pre-closing investments by Mynaric's sellers impacted the final purchase price and reduced earnout potential.
- 6Mynaric's sellers are no longer eligible for further earnout payments, subject to post-closing adjustments.
- 7The equity issued for the acquisition was conducted under Section 4(a)(2) and Regulation D, exempting it from registration.